Status:
COMPLETED
The Subvastus Approach in Total Knee Arthroplasty
Lead Sponsor:
Nova Scotia Health Authority
Conditions:
Osteoarthritis
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine if the observed benefits of minimally invasive total knee arthroplasty, namely decreased hospital stay and increased range of motion, can be achieved with sta...
Eligibility Criteria
Inclusion
- You are willing to take part in the study, including signing this form after carefully reading it.
- You are available for follow-up for a minimum of 24 months (2 years).
- You have no medical conditions that prevent you from having surgery.
- This is the primary (first) knee replacement for this knee
- You are fluent in English and are able to understand your responsibilities in this study.
Exclusion
- Active, local or systemic infection
- Fibromyalgia or other chronic pain syndrome
- Inability to follow the study requirements
- Had this knee replaced before
- Had a previous surgery on this knee that would interfere with the MIS approach (examples are femoral-femoral bypass, femoral-popliteal bypass, and quadricepsplasty)
- Body Mass Index (BMI) \> 35, as you would not be eligible for the MIS approach.
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2011
Estimated Enrollment :
126 Patients enrolled
Trial Details
Trial ID
NCT00346788
Start Date
January 1 2005
End Date
March 1 2011
Last Update
February 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
QEII Health Sciences Centre
Halifax, Nova Scotia, Canada, B3H 3A7